tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

InhaleRx Limited Reports Increased Half-Year Loss Amidst Financial Challenges

Story Highlights
InhaleRx Limited Reports Increased Half-Year Loss Amidst Financial Challenges

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.

InhaleRx Limited reported a 15.8% increase in its half-year loss, amounting to $854,332 for the period ending June 30, 2025, compared to the previous year’s loss of $737,576. The company did not declare any dividends during this period, and its net tangible assets per ordinary security decreased significantly from (0.03) cents to (0.41) cents, indicating a challenging financial performance.

More about InhaleRx Limited

InhaleRx Limited operates in the healthcare industry, focusing on the development and provision of inhalation-based therapies. The company is dedicated to advancing medical treatments through innovative inhalation technologies.

Average Trading Volume: 267,657

Technical Sentiment Signal: Buy

Current Market Cap: A$7.47M

Learn more about IRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1